Overview: VascuLogic develops and commercializes image guided medical devices, for use in difficult venous access situations. Specifically, Vasculogic has developed an automated venipuncture device that will assist healthcare professionals in hospitals, physician offices, and labs to stick a patent one-time with 98% accuracy. Additionally, VascuLogic is developing a panel of microfluidic assay platforms-popularly known as “lab-on-chip” systems-for use in point of care diagnostic applications, and related fields, to work with the venous access devices. Mission: VascuLogic’s mission is to establish its products as the preeminent technological substitute for human intervention in difficult venous access patients. VascuLogic does not purport totally to supplant human-executed venipuncture, however it will provide phlebotomists and clinicians with a technology to enable first stick accuracy at significantly higher levels then are currently obtainable in the difficult venous access space. This enhanced accuracy will markedly reduce patient discomfort as well as cost to the clinical facility. In the course of achieving this mission, VascuLogic will pioneer, lead and dominate a newly emerging clinical market segment of robotics-assisted venous access. VascuLogic’s VenousProTM brand is, in the true sense of the term, a disruptive technology.